The company is not going back and retesting. The three new trials are completely different to the original. I think you may have been effected by the negative spin doctors on here.
The original HER-Vaxx trial was just testing HER-Vaxx alone, for safety and efficacy.
NextHERIZON, NeoHERIZON and NeuHERIZON are all combination therapy trials. This has been the plan for HER-Vaxx all along. From day one, HER-Vaxx' path was meant to be for combination therapy, not as a monotherapy.
In addition, the three new trials will also be expanded to include early stage patients, as per announcement.
Don't be fooled by the comments from the negative spin doctors and people like Tom Richardson, the HER-Vaxx trial did not fail, nor was it "underwhelming". It did exactly what it was designed to do.
People like Tom Richardson are generalists. The phrase, what goes up must come down, is the extent of his expertise in this sector.
Ann: Imugene HER-Vaxx Phase 2 PFS Data and Flags Three New Trials, page-297
-
- There are more pages in this discussion • 49 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add IMU (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
5.7¢ |
Change
0.003(5.56%) |
Mkt cap ! $417.2M | |||
| Open | High | Low | Value | Volume |
| 5.5¢ | 5.8¢ | 5.2¢ | $2.499M | 45.00M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 1921794 | 5.6¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 5.7¢ | 1368288 | 7 |
View Market Depth
| Last trade - 16.10pm 28/06/2024 (20 minute delay) ? |
| IMU (ASX) Chart |